Тёмный
No video :(

Testing for Common and Uncommon EGFR Mutations to Guide EGFR-Targeted Therapy in NSCLC 

PeerView Oncology
Подписаться 7 тыс.
Просмотров 738
50% 1

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC information, and to apply for credit, please visit us at PeerView.com/KYJ865. CME/MOC/CC credit will be available until January 24, 2025.
Mastering the Testing for Common and Uncommon EGFR Mutations to Guide EGFR-Targeted Therapy in Advanced NSCLC
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Опубликовано:

 

14 авг 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии    
Далее
ROLLING DOWN
00:20
Просмотров 6 млн
2023 Best of Lung: Targeted Therapies in Lung Cancer
30:32
EGFR mutation analysis
39:35
Просмотров 6 тыс.
EGFR Mutant Lung Cancer: 2013 Update
45:43
Просмотров 3,7 тыс.
Atrial Fibrillation: New Solutions for an Old Problem
38:36